Q2. What is the role of eosinophils in antiviral immunity?
Eosinophil NO production contributes to antiviral immunity from RSVNitric oxide (NO) has been implicated in antiviral host defense and may also be functionally protective through bronchodilatory mechanisms.
Q3. What is the role of TLRs in the accelerated clearance of RSV?
The immediate response to RSV infection in immunocompetent hosts includes recruitment of proinflammatory granulocytes, which themselves express TLRs.
Q4. How did eosinophil transfer reduce AHR in RSV-infected?
Eosinophil transfer reduces AHR in RSV-infected miceBecause RSV infection has been associated with AHR, the authors next examined whether eosinophil-mediated viral clearance could suppress RSV-induced AHR.
Q5. What is the role of eosinophils in promoting antiviral immunity?
Eosinophils directly transferred into the airways have been shown to remain functional and can migrate into the lung and local pulmonary lymph nodes, where they actively participate in immune responses.
Q6. What is the role of eosinophils in the modulation of immune or?
it is likely that the role ofeosinophils in the modulation of immune or pathologic processes is highly dependent on signals received from the microenvironment and signals that are associated with specific inflammatory responses.
Q7. What is the role of TLRs in the development of adaptive immune responses?
the authors show that eosinophil-mediated accelerated RSV clearance and attenuated lung dysfunction are dependent on the TIR adaptor molecule MyD88 and the production of NO by NOS-2.TLRs are a conserved family of PRRs that bridge innate pathogen recognition and the development of adaptive (T and B lymphocyte) immune responses.
Q8. What is the role of eosinophils in the inflammatory process?
In the setting of allergic asthma, where eosinophils are prevalent in the airway mucosa and exacerbations of disease are most frequently caused by viral infections, eosinophils have often been implicated as a causative agent of AHR.49-51
Q9. What is the effect of RSV infection on the lungs of mice?
RSV infection resulted in an increase in the number of goblet cells secreting mucus into the airways in both hypereosinophilic and WT mice within 24 hours (data not shown).
Q10. What is the effect of L-NMA on the clearance of RSV in WT mice?
L-NMA significantly delayed the clearance of RSV in WT mice, and completely reversed the advantage conferred by the hypereosinophilic status of IL-5 Tg mice (Figure 5C).
Q11. How did the authors determine that accelerated virus clearance was due to eosinophils?
To confirm that accelerated virus clearance was due specifically to eosinophils and not the overexpression of IL-5, the authors FACSpurified eosinophils ( 98% pure) from the spleens of hypereosinophilic mice, and performed an adoptive transfer directly into the lungs of WT mice 2 hours before RSV inoculation.
Q12. How did the authors determine whether eosinophils confer protection from RSV?
To demonstrate that eosinophils confer protection from RSV, the authors used dblGATA mice, whose eosinophil lineage is selectively and severely disrupted.
Q13. What was the RNA integrity of the eosinophils recovered by FACS?
Eosinophils recovered by FACS (BD Biosciences FACS Vantage Diva) were approximately 99% pure as determined by Giemsa-stained cytospin preparations.
Q14. How does the mouse show that TLR-7 can recognize RSV?
In the mouse, the authors demonstrate at the protein level that eosinophils express another TLR that can recognize molecular patterns expressed by RSV, namely TLR-7.
Q15. What did the authors find out about the effect of RSV on eosinophils?
Having demonstrated that RSV induces systemic effects, the authors next determined if antiviral genes were induced in eosinophils in response to infection.